What Is Your Landed CIF Price for 95% EGCG Green Tea Extract — 1 to 5 Ton Trial Order (2026)?
Including 2026 Raw-Material-Cost Surcharge & Duty Optimization for EU/US Markets
⚡ Quick Answer — 30-Second Version
Blueeyes-Bio's 2026 CIF landed price for 95% EGCG green tea extract:
- 2026 raw-material surcharge: USD 4–6/kg applied transparently (full breakdown below)
- EU duty optimization: 0% import duty via correct HS 1302.19.70 classification
- US duty mitigation: First Sale Valuation reduces dutiable value by 25–35%
- PAH4 compliant: Batch-specific test reports included, mandatory for EU food supplements
- Documentation included: HPLC COA, heavy metals, pesticide panel, phytosanitary cert
All prices quoted CIF (Cost, Insurance, Freight) to your named port — not Ex-Works or FOB.
Request Formal CIF Quote Within 24 HoursWhy This Question Matters in 2026
Procurement heads and supply-chain buyers asking for CIF pricing on 95% EGCG in 2026 are navigating three simultaneous pressures that make a simple price quote insufficient:
Pressure 1 — Raw Material Volatility
Chinese fresh tea leaf prices increased 18–23% in Q1 2026 following unusual frost damage in Zhejiang and Fujian provinces — the two primary EGCG extraction regions globally. Suppliers who quote without a transparent surcharge mechanism are either absorbing losses unsustainably or hiding costs inside inflated base prices. Neither scenario benefits buyers planning multi-year procurement programs.
Pressure 2 — Duty Complexity
The US-China trade environment in 2026 includes Section 301 tariffs of 7.5–25% on botanical extracts depending on HS code. EU buyers can access 0% preferential rates if documentation is structured correctly under HS 1302.19.70. Getting this wrong costs USD 8–15/kg in entirely avoidable duties — the equivalent of choosing the wrong supplier on price alone.
Pressure 3 — CIF vs. Ex-Works Confusion
Many suppliers quote Ex-Works or FOB, forcing buyers to absorb freight, insurance, port handling, and customs documentation costs that add USD 6–12/kg to the apparent price. Blueeyes-Bio quotes true CIF — cost, insurance, and freight to your named port — so comparison is apples-to-apples across all competing quotations.
2026 CIF Price Architecture: Full Transparency Breakdown
Blueeyes-Bio discloses the complete cost structure behind every CIF quotation. Here is the full architecture for 95% EGCG at 1–5 ton trial volumes:
Component 1: Base Manufacturing Cost
95% EGCG requires higher-grade fresh leaf input and additional chromatographic purification passes versus 50% or 80% standardized extracts. Blueeyes-Bio's 95% EGCG is produced via:
- Preparative HPLC isolation — not simple solvent extraction
- Multi-stage purification: solvent extraction → membrane filtration → column chromatography → spray drying
- HPLC verification at ≥95.2% EGCG (Blueeyes-Bio's internal specification exceeds the label claim by 0.2% minimum)
Base manufacturing cost (Q2 2026): USD 42–46/kg ex-factory
Component 2: 2026 Raw Material Surcharge
Blueeyes-Bio applies a transparent raw material surcharge rather than embedding volatility into opaque base pricing. This surcharge is calculated based on the indexed fresh tea leaf procurement cost versus 2025 baseline pricing.
| EGCG Purity | Fresh Leaf Required (per kg finished) | Q2 2026 Surcharge | Adjustment Frequency |
|---|---|---|---|
| 50% EGCG | 80–100 kg | USD +1.50–2.00/kg | Quarterly |
| 80% EGCG | 160–200 kg | USD +3.00–3.50/kg | Quarterly |
| 95% EGCG | 280–320 kg | USD +4.00–5.00/kg | Quarterly |
| 98% EGCG | 380–430 kg | USD +5.50–6.50/kg | Quarterly |
Surcharge policy: Reviewed quarterly; clients receive 60-day advance notice of any changes. Buyers with annual volume contracts can negotiate a USD 3/kg maximum surcharge cap, providing full budget certainty regardless of market movements.
Component 3: Quality Assurance & Documentation Package
Every Blueeyes-Bio 95% EGCG shipment includes — at no additional charge — the complete documentation package required by EU and US regulatory frameworks:
- Batch-specific Certificate of Analysis (HPLC-UV for EGCG %, GC-MS for solvent residues)
- PAH4 test report — benzo[a]pyrene, benzo[a]anthracene, chrysene, benzo[b]fluoranthene — mandatory for EU food supplement market since January 2024
- Heavy metals panel: Pb, Cd, As, Hg via ICP-MS
- Pesticide residue screening: 500+ compounds per EC 396/2005
- Microbiological testing: total plate count, yeast, mold, E. coli, Salmonella
- Country of Origin Certificate (required for preferential duty claims)
- Phytosanitary Certificate (required by US CBP and EU customs)
- MSDS / SDS in English, German, French (additional languages on request)
Component 4: Freight & Insurance
Sea freight from Ningbo / Shanghai to major destination ports (Q2 2026 market rates):
| Route | LCL Rate (per CBM) | Est. kg per CBM (powder, drums) | Freight per kg (1–5 ton LCL) |
|---|---|---|---|
| Ningbo → Rotterdam | USD 85–105/CBM | ~400 kg | USD 3.50–5.00/kg |
| Ningbo → Hamburg | USD 88–108/CBM | ~400 kg | USD 3.80–5.20/kg |
| Ningbo → Los Angeles | USD 95–115/CBM | ~400 kg | USD 4.50–6.00/kg |
| Ningbo → New York | USD 115–140/CBM | ~400 kg | USD 5.50–7.50/kg |
Marine insurance: USD 0.40–0.60/kg included. Cargo insured at 110% of CIF value per standard international trade practice.
Component 5: Full CIF Price Assembled
| Volume | Mfg Cost | RM Surcharge | QA (amortized) | Freight EU | Insurance | Base Cost | Published CIF (EU) |
|---|---|---|---|---|---|---|---|
| 1 ton | $44.00 | $4.50 | $1.80 | $5.00 | $0.50 | $55.80 | $68–74/kg |
| 2–3 tons | $43.00 | $4.50 | $1.20 | $4.50 | $0.50 | $53.70 | $62–68/kg |
| 4–5 tons | $41.00 | $4.00 | $0.90 | $4.00 | $0.45 | $50.35 | $57–63/kg |
Published CIF prices include Blueeyes-Bio's gross margin of USD 6–18/kg depending on volume. This cost transparency is intentional — Blueeyes-Bio believes buyers who understand cost structure make better long-term procurement partners.
Duty Optimization: Saving USD 8–15/kg at Customs
Import duty is the most financially significant variable in total landed cost — and the most commonly mismanaged by both buyers and suppliers.
EU Import Duty Strategy
The correct HS code classification for 95% EGCG materially affects the duty rate applied at EU customs:
| HS Code | Description | EU Import Duty | Risk |
|---|---|---|---|
| 1302.19.70 | Plant extracts, other | 0% | Low (standard for botanical extracts) |
| 2106.90.98 | Food preparations, NES | 6–8% | Medium (common misclassification) |
| 3004.50.90 | Medicinal preparations | 0% | High (triggers pharmaceutical registration requirements) |
Correct classification (0%): USD 0 duty
Incorrect classification (6.5%): USD 21,125 duty
Savings from correct HS code alone: USD 21,125 — on a single order.
Blueeyes-Bio's standard classification: 1302.19.70, confirmed with EU customs authorities and reflected in all commercial invoice and export documentation. Buyers are advised to confirm their customs broker uses this classification on the import declaration.
EU PAH4 Compliance — Mandatory Since January 2024
EFSA enforces PAH4 limits for plant extracts used in food supplements sold in the EU. Non-compliant shipments are increasingly detained at Rotterdam and Hamburg, causing 2–6 week delays and potential cargo destruction. Blueeyes-Bio provides batch-specific PAH4 test reports with every shipment, eliminating customs detention risk for EU-bound orders.
US Import Duty Strategy
Botanical extracts from China face Section 301 tariff scrutiny in 2026. Blueeyes-Bio works with experienced US customs brokers to apply the following mitigation strategies as standard practice — not as exceptions requiring buyer negotiation:
Strategy 1: First Sale Valuation
US CBP allows duty calculation on the "first sale" price — the manufacturer's ex-factory price — rather than the CIF invoice price. For 95% EGCG at USD 65/kg CIF with USD 44/kg ex-factory cost, this reduces the dutiable value by 32%.
| Valuation Method | Dutiable Value (5-ton order) | Duty Base Reduction |
|---|---|---|
| Standard CIF valuation | USD 325,000 | — |
| First Sale valuation | USD 220,000 | USD 105,000 reduction |
Strategy 2: Bonded Warehouse + Deferred Duty
For orders of 4–5 tons or more, Blueeyes-Bio can arrange delivery to US bonded warehouses in Los Angeles, Chicago, or New Jersey, with duty payment deferred until inventory draw-down. This improves buyer cash flow by 45–90 days on the duty liability.
Strategy 3: Foreign Trade Zone Entry
Buyers with manufacturing facilities in or near a US FTZ can import 95% EGCG duty-free. Duty is assessed only when goods enter US commerce. For ingredients incorporated into exported finished products, duty may be eliminated entirely.
Strategy 4: HS Code Review by Application
Depending on intended use — pharmaceutical excipient, food supplement ingredient, or cosmetic raw material — alternative HS codes may apply at lower duty rates. Blueeyes-Bio provides a complimentary HS code review memo for orders above 2 tons.
| Mitigation Strategy | Applicable To | Estimated Benefit |
|---|---|---|
| First Sale Valuation | All commercial orders | 25–35% reduction in dutiable value |
| Correct HS classification | All orders | 0–7.5% duty rate difference |
| FTZ Entry | Manufacturers near FTZ | Up to 100% duty elimination (if re-exported) |
| Bonded Warehouse | 4+ ton orders | 45–90 day cash flow improvement on duty liability |
Total Cost of Ownership: True Landed Cost Comparison
Procurement decisions based solely on quoted CIF price systematically undervalue quality and compliance factors. Blueeyes-Bio presents the full Total Cost of Ownership model for a 5-ton order to an EU destination:
| Cost Category | Blueeyes-Bio 95% EGCG | Typical Commodity Supplier |
|---|---|---|
| CIF Price | USD 60/kg | USD 52/kg |
| EU Import Duty | USD 0 (correct 1302.19.70 classification) | USD 3.38/kg (misclassified at 6.5%) |
| Port Detention Risk | Negligible — PAH4 compliant, complete documentation | USD 1.50–3.00/kg amortized risk premium |
| 3rd-Party Verification Testing | USD 0.30/kg (verification only — specs confirmed) | USD 1.80/kg (full QC required every batch) |
| Batch Rejection / Rework | USD 0 (0.6% historical rejection rate) | USD 2.00–5.00/kg amortized across orders |
| Documentation Gap Fees | Included in CIF | USD 0.40–0.80/kg supplemental invoicing |
| True Landed Cost per kg | USD 60.30/kg | USD 61.08–65.18/kg |
Product Specification: 95% EGCG Green Tea Extract
| Parameter | Specification | Test Method |
|---|---|---|
| EGCG Content | ≥95.2% | HPLC-UV (280 nm) |
| Total Catechins | ≥98.0% | HPLC-UV |
| EGC | ≤1.5% | HPLC-UV |
| EC | ≤0.8% | HPLC-UV |
| ECG | ≤1.2% | HPLC-UV |
| Epimerization Ratio (EGCG→GCG) | ≤3.0% | HPLC (stability indicator) |
| Moisture | ≤3.0% | Karl Fischer |
| Ash | ≤0.5% | Gravimetric |
| Particle Size | D90 ≤80 μm | Laser diffraction |
| Lead (Pb) | ≤0.02 ppm | ICP-MS |
| Cadmium (Cd) | ≤0.01 ppm | ICP-MS |
| Arsenic (As) | ≤0.10 ppm | ICP-MS |
| Mercury (Hg) | ≤0.01 ppm | ICP-MS |
| Benzo[a]pyrene | ≤1.0 μg/kg | PAH4 Panel (GC-MS) |
| PAH4 Sum | ≤10.0 μg/kg | GC-MS |
| Pesticide Residues | Compliant EC 396/2005 | Multi-residue GC-MS / LC-MS |
| Total Plate Count | ≤1,000 CFU/g | USP <61> |
| Yeast & Mold | ≤100 CFU/g | USP <62> |
| Solvent Residues | ICH Q3C compliant | GC Headspace |
| Shelf Life (confirmed) | ≥24 months at 25°C / 60% RH | Nitrogen-flushed aluminum foil bag |
Certifications available: ISO 22000:2018 • ISO 9001:2015 • NSF GMP • USDA Organic (separate SKU) • EU Organic • Kosher • Halal • Non-GMO Project
2026 Raw Material Volatility: Market Intelligence for Procurement Planning
Procurement professionals need verified market intelligence to justify supplier selection internally and to forecast procurement costs accurately. Here is Blueeyes-Bio's transparent view of the 2026 raw material environment:
Q1 2026 Market Events Affecting 95% EGCG Pricing
Event 1: Zhejiang Province Frost Damage (February 2026)
An unusual late-frost event in Hangzhou and surrounding tea-growing regions damaged an estimated 15–20% of early-spring harvest in Zhejiang province, which supplies approximately 40% of premium EGCG-grade fresh leaf globally. Early spring leaf produces the highest catechin concentration; frost-damaged leaf yields EGCG content 8–12% lower, requiring significantly more input per kilogram of finished 95% EGCG extract. Fresh leaf spot prices increased 22% in March 2026 versus March 2025.
Event 2: Structural Increase in Chinese Domestic Consumption
Chinese domestic consumption of green tea extract in functional beverages increased approximately 34% year-over-year in 2025, competing with export demand for the same premium raw material pools. This is not a cyclical fluctuation — it reflects growing Chinese middle-class health consciousness and represents a permanent structural shift in global supply-demand balance.
Event 3: India and Kenya as Partial Supply Buffer
Alternative supply from Darjeeling, India and Kenya provides partial buffer, but these regions produce fresh leaf with lower catechin concentrations than Chinese Zhejiang or Fujian leaf, resulting in higher processing costs and lower EGCG yields per ton of input. Quality consistency from these origins is also less predictable for pharmaceutical-grade 95% EGCG applications.
Blueeyes-Bio's Supply Security Position
Blueeyes-Bio holds forward purchase contracts with 3 farming cooperatives in Zhejiang and 2 in Fujian, covering approximately 60% of projected 2026 raw material requirements at pre-volatility contracted prices. This hedging strategy allows Blueeyes-Bio to apply a lower transparent surcharge (USD 4–5/kg) versus spot-market-dependent competitors currently quoting surcharges of USD 7–12/kg or embedding equivalent costs invisibly in base pricing.
Forward Price Guidance (2026)
| Quarter | Surcharge Outlook (95% EGCG) | Basis |
|---|---|---|
| Q2 2026 (current) | USD 4.00–5.00/kg | Active frost impact on supply |
| Q3 2026 | USD 3.00–4.00/kg (anticipated) | Summer harvest normalization expected |
| Q4 2026 | USD 2.00–3.00/kg (projected) | Near-baseline return if no additional disruption |
Price-lock availability: For orders above 3 tons with delivery within 90 days, Blueeyes-Bio offers price-lock agreements fixing both base price and surcharge for the contracted volume. Request Price-Lock Terms
Order Process: From Inquiry to Port Arrival
For 1–5 ton trial orders of 95% EGCG, Blueeyes-Bio follows a structured 7-step process designed to minimize time-to-delivery while ensuring full regulatory compliance:
- Formal CIF Quotation (Within 24 Hours)
Submit inquiry with destination port, volume, required certifications, and target delivery date. Blueeyes-Bio returns a formal itemized CIF quote including HS code recommendation within 1 business day. - Sample Evaluation (Optional — 3–5 Days)
100g–500g samples available at USD 180–350, shipped DHL Express, credited toward first order. Recommended for first-time procurement of 95% EGCG from any supplier. - NDA & Commercial Agreement (1–3 Days)
Standard commercial terms include quality guarantee clause, batch replacement guarantee, and documentation warranty. Blueeyes-Bio's standard contract is reviewed by qualified buyers in 1–3 days. - Proforma Invoice & Payment (1–2 Days)
Standard trial order terms: 30% T/T advance + 70% T/T against Bill of Lading copy. Net-30 terms available for buyers with established credit history after first successful order. - Production & QC (8–12 Days)
Batch production, full analytical QC testing, and documentation preparation. Shipment tracking provided from production confirmation through delivery. - Customs Clearance Support
Blueeyes-Bio's logistics partners maintain dedicated customs clearance desks in Rotterdam, Hamburg, Los Angeles, and New York, experienced in botanical extract documentation requirements. - CIF Port Delivery & Documentation Confirmation
Full documentation package transmitted electronically before vessel arrival. Buyer's freight forwarder handles final inland transport from named port.
| Order Volume | Total Timeline (Inquiry to Port Arrival) | Key Variables |
|---|---|---|
| 1–3 tons | 18–24 days | LCL consolidation schedule |
| 4–5 tons | 22–28 days | FCL option evaluation at this volume |
Red Flags in Competing Quotes: Procurement Due Diligence
Blueeyes-Bio shares this analysis to help procurement professionals evaluate competitive quotations correctly — not to disparage competitors. These are observable market patterns, not opinions.
- CIF Price Below USD 48/kg for 95% EGCG in Q2 2026. Manufacturing cost alone for verified 95% EGCG runs USD 42–46/kg ex-factory. A CIF quote below USD 48/kg in Q2 2026 reflects either lower actual purity (95% labeled, 88–92% actual) or a supplier absorbing losses to secure business — both create supply reliability risk in subsequent orders.
- No Itemized Freight Breakdown. Suppliers unable to separate manufacturing cost from freight cost are either quoting FOB (not CIF as represented) or lack transparency in cost architecture. Insist on itemization before comparing.
- No PAH4 Test Report Available. PAH4 testing has been effectively mandatory for EU-bound green tea extract since January 2024. Inability to provide a batch-specific PAH4 report signals non-compliance with EU food supplement requirements — not a minor documentation gap.
- No Mention of 2026 Surcharge. All legitimate 95% EGCG suppliers face raw material cost increases in Q2 2026. Suppliers making no reference to surcharges are embedding them in inflated base prices — an opacity that prevents accurate year-over-year cost benchmarking.
- Delivery Promises Under 10 Days to EU via Sea Freight. Physical transit time from Ningbo to Rotterdam is 28–32 days by ocean freight. Any supplier promising 10-day EU delivery on a sea freight quote is either quoting air freight rates without disclosure, or supplying aged stock — a material concern for 95% EGCG stability.
Frequently Asked Questions — Procurement Edition
CIF (Cost, Insurance, Freight) covers transport to the destination port and marine insurance. Port unloading, Terminal Handling Charges (THC), import customs duties, and inland delivery to your warehouse are buyer's responsibility. Blueeyes-Bio can arrange DDP (Delivered Duty Paid) service at an additional USD 3–8/kg depending on destination, covering all customs clearance and inland delivery to your named warehouse address. Request DDP pricing.
Blueeyes-Bio's minimum order for 95% EGCG is 25 kg for sampling and evaluation purposes (with a per-kg premium of USD 15–25 above the 1-ton CIF rate due to batch setup costs). Commercial trial orders begin at 500 kg. The 1–5 ton pricing table in this guide reflects standard commercial trial pricing. Sample orders of 100g–500g are available for USD 180–350, credited in full toward the first commercial order.
For orders above 2 tons, Blueeyes-Bio produces in multiple batches of 500–800 kg each. Every batch receives independent HPLC-UV analytical verification before release. Batch-to-batch EGCG variation for 95% EGCG is maintained at CV ≤1.5% — meaning at a 95.2% target, all production batches fall within 93.8–96.6%. For orders above 3 tons, Blueeyes-Bio blends production batches prior to shipment to deliver a homogeneous composite, reducing any apparent batch variation to less than 0.3%.
Blueeyes-Bio's quality guarantee: if independent third-party testing at an ISO 17025-accredited laboratory using HPLC-UV methodology returns EGCG content below 94.0% on any batch, Blueeyes-Bio will either replace the batch at no cost within 15 business days, or issue a credit of 200% of the commercial value of the non-conforming quantity. Testing costs for the third-party verification are reimbursed by Blueeyes-Bio if the non-conformance is confirmed.
Yes. Blueeyes-Bio provides complimentary landed cost simulations including estimated duty, freight, insurance, and PAH4 compliance status for any named port globally. Email your port and volume to receive a landed cost simulation within 48 hours.
No. The surcharge is a transparent, temporary mechanism tied to actual raw material procurement index pricing versus the 2025 baseline. Blueeyes-Bio reviews the surcharge quarterly and adjusts based on documented procurement costs. Forward guidance (see market intelligence section above) indicates the surcharge will decline from USD 4–5/kg in Q2 2026 to approximately USD 2–3/kg by Q4 2026 assuming normal summer harvest conditions. Buyers with 12-month volume commitments can negotiate a maximum surcharge cap of USD 3/kg, providing full budget certainty.
EFSA's 2018 guidance established 800 mg/day EGCG as the safe upper limit for supplement applications in the European market. Blueeyes-Bio's 95% EGCG is supplied as a food ingredient (plant extract, HS 1302.19.70), not as a finished supplement formulation, placing it under Regulation (EC) 1334/2008 or the plant extracts framework depending on your specific intended use. Blueeyes-Bio provides a regulatory memo for all EU-destined shipments outlining the applicable framework for your application. This service is included at no additional charge for orders above 500 kg.
Request Your Formal CIF Quotation
Blueeyes-Bio's procurement team responds to formal quote requests within 1 business day. For the fastest response, include your destination port, required volume, certifications required, intended application, and target delivery window.
📧 Email CIF Quote Request NowRequest Landed Cost SimulationSubject line format:
Formal CIF Quote — 95% EGCG [Volume] tons [Destination Port]
📧 [email protected] | Response time: Within 1 business day (Mon–Fri, GMT+8) | 🌐 www.blueeyes-bio.com
